UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
Commission File Number: 01-28911
Notification of Late Filing
(Check one)
|_| Form 10-K |_| Form 11-K |X| Form 10-Q |_| Form N-SAR
| | Form 10-KSB
For Period Ended: December 31, 2004
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: N/A
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates:
PART I
REGISTRANT INFORMATION
NATIONAL HEALTHCARE TECHNOLOGY, INC.
--------------------------------------------------------------------------------
Full name of Registrant
-------------------------
Former Name if Applicable
20700 Ventura Blvd. Suite 227
--------------------------------------------------------------------------------
Address of principal executive offices(Street and Number)
Woodland Hills, California 91364
--------------------------------------------------------------------------------
City, State and Zip Code
PART II
RULES 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check appropriate box.) [ ] Yes [ ] No
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense.
[X] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, 20-F, 11-K or N-SAR, or portion thereof, will be filed on or
before the 15th calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion
thereof, will be filed on or before the fifth calendar day following
the prescribed due date.
[ ] The accountant's statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail the reasons why Form 10-K, 11-K, 20-F, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
The Registrant's quarterly report on Form 10-QSB will be filed on or
before the fifth calendar following the prescribed due date. The reason for the
delay is that the Registrant is waiting for certain information from a third
party.
PART IV
OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Charles Smith (818) 887-7201
--------------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or such shorter
period that the registrant was required to file such report(s) been
filed? If answer is no, identify report(s). [x] Yes [ ] No
(3) Is it anticipated that any significant change in results of operation
for the corresponding period for the last fiscal year will be reflected
by the earnings statements to be included in the subject report or
portion thereof? [ ] Yes [x] No
If so, attach an explanation of anticipated change, both narratively
and quantitatively, and if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
NATIONAL HEALTHCARE TECHNOLOGY, INC.
--------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date February 14, 2005 By:/s/ Charles Smith
-----------------
Charles Smith, CFO
Instruction: The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and
title of the person signing the form shall be typed or printed beneath the
signature. If the statement is signed on behalf of the registrant by an
authorized representative (other than executive officer), evidence of the
representative=s authority to sign on behalf of the registrant shall be
filed with the form.
ATTENTION
Intention misstatements or omissions of fact constitute Federal criminal
violations. (See 18 U.S.C. 1001)